ACC.24 - Can the way patients are educated and medications prescribed be improved? Alexander Blood shares the results of the DRIVE study.
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Share
Save
Restart
Resume
Transcript
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
closeShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Alexander Blood, MD is cardiologist as well as a critical care physician at Brigham and Women's Hospital in Boston, MA, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 10 april 2024
Recommended
Details
Presenters
Overview
ACC.24 - Can the way patients are educated and medications prescribed be improved? Alexander Blood shares the results of the DRIVE study.
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Alexander Blood, MD is cardiologist as well as a critical care physician at Brigham and Women's Hospital in Boston, MA, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 10 april 2024
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?